Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Hamilton Insurance Group
HG
$3.54B
| $667K | ﹤0.01% |
40,062
+2,225
| +6% | +$34K |
|
|
IAUX
3077
i-80 Gold Corp
IAUX
$1.16B
| $666K | ﹤0.01% |
616,749
+172,531
| +39% | +$202K |
|
3078
iShares S&P GSCI Commodity-Indexed Trust
GSG
$995M
| $665K | ﹤0.01% |
30,001
+14,323
| +91% | +$319K |
|
3079
Bitdeer Technologies
BTDR
$2.7B
| $664K | ﹤0.01% |
64,724
-33,352
| -34% | -$229K |
|
|
HSHP
3080
Himalaya Shipping
HSHP
$733M
| $663K | ﹤0.01% |
72,404
+3,181
| +5% | +$27K |
|
3081
Lifezone Metals
LZM
$301M
| $663K | ﹤0.01% |
+86,329
| New | +$673K |
|
3082
Codexis
CDXS
$159M
| $662K | ﹤0.01% |
213,567
+9,013
| +4% | +$28.9K |
|
3083
TScan Therapeutics
TCRX
$49.4M
| $661K | ﹤0.01% |
112,941
+90,837
| +411% | +$715K |
|
3084
AerSale
ASLE
$291M
| $653K | ﹤0.01% |
94,303
+4,396
| +5% | +$31.5K |
|
3085
Viemed Healthcare
VMD
$451M
| $651K | ﹤0.01% |
99,368
+8,050
| +9% | +$60.7K |
|
3086
Kodiak Sciences
KOD
$2.66B
| $650K | ﹤0.01% |
276,550
+13,274
| +5% | +$45K |
|
3087
Northeast Community Bancorp
NECB
$366M
| $646K | ﹤0.01% |
36,231
+3,472
| +11% | +$57.1K |
|
|
SEI
3088
Solaris Energy Infrastructure
SEI
$3.14B
| $644K | ﹤0.01% |
75,041
-7,722
| -9% | -$67.5K |
|
3089
Utah Medical Products
UTMD
$222M
| $643K | ﹤0.01% |
9,630
-99
| -1% | -$6.74K |
|
|
INZY
3090
DELISTED
Inozyme Pharma
INZY
| $638K | ﹤0.01% |
143,158
+16,623
| +13% | +$80.6K |
|
3091
The Honest Company
HNST
$409M
| $637K | ﹤0.01% |
218,188
+188,721
| +640% | +$561K |
|
3092
Rigel Pharmaceuticals
RIGL
$704M
| $636K | ﹤0.01% |
77,409
+3,047
| +4% | +$31.9K |
|
3093
Ezcorp Inc
EZPW
$1.79B
| $636K | ﹤0.01% |
60,724
+6,612
| +12% | +$69.7K |
|
3094
Sutro Biopharma
STRO
$411M
| $635K | ﹤0.01% |
21,683
+5,595
| +35% | +$221K |
|
|
RAPT
3095
DELISTED
RAPT Therapeutics
RAPT
| $635K | ﹤0.01% |
26,017
-3,440
| -12% | -$159K |
|
3096
Southern First Bancshares
SFST
$579M
| $631K | ﹤0.01% |
21,566
+1,056
| +5% | +$29K |
|
|
AIRJ
3097
Montana Technologies Corp
AIRJ
$318M
| $629K | ﹤0.01% |
+61,019
| New | +$714K |
|
|
MRSN
3098
DELISTED
Mersana Therapeutics
MRSN
| $628K | ﹤0.01% |
12,505
+670
| +6% | +$48.4K |
|
3099
Park-Ohio Holdings
PKOH
$568M
| $628K | ﹤0.01% |
24,239
+1,221
| +5% | +$31K |
|
3100
Vanguard Consumer Discretionary ETF
VCR
$5.98B
| $623K | ﹤0.01% |
1,996
+191
| +11% | +$58.5K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.